WSC
RPRX icon

Wellington Shields & Co’s Royalty Pharma RPRX Stock Holding History

Wellington Shields & Co’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-34,318
Closed -$1.36M – 308
2022
Q4 		$1.36M Sell
34,318
-53,559
-61% -$2.24M 0.31% 44
2022
Q3 		$3.53M Hold
87,877
– – 1.54% 12
2022
Q2 		$3.69M Hold
87,877
– – 0.9% 12
2022
Q1 		$3.42M Hold
87,877
– – 1.13% 19
2021
Q4 		$3.5M Sell
87,877
-3,293
-4% -$128K 0.7% 22
2021
Q3 		$3.29M Hold
91,170
– – 1.15% 19
2021
Q2 		$3.74M Sell
91,170
-2,500
-3% -$106K 1.23% 13
2021
Q1 		$4.09M Sell
93,670
-1,000
-1% -$47.4K 1.46% 11
2020
Q4 		$4.74M Buy
+94,670
New +$4.02M 1.7% 11

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return